financetom
Business
financetom
/
Business
/
Ha Sustainable Infrastructure Capital Insider Sold Shares Worth $335,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ha Sustainable Infrastructure Capital Insider Sold Shares Worth $335,000, According to a Recent SEC Filing
Sep 13, 2024 1:36 PM

04:33 PM EDT, 09/12/2024 (MT Newswires) -- Nathaniel Rose, Executive Vice President & Chief Investment Officer, on September 11, 2024, sold 10,000 shares in Ha Sustainable Infrastructure Capital ( HASI ) for $335,000. Following the Form 4 filing with the SEC, Rose has control over a total of 156,164 shares of the company, with 153,164 shares held directly and 3,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1561894/000156189424000099/xslF345X05/wk-form4_1726172840.xml

Price: 34.75, Change: +0.10, Percent Change: +0.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CareTrust Acquires Nursing Portfolio in Mid-Atlantic for About $74.7 Million
CareTrust Acquires Nursing Portfolio in Mid-Atlantic for About $74.7 Million
Oct 3, 2024
05:38 AM EDT, 10/03/2024 (MT Newswires) -- CareTrust REIT ( CTRE ) said Thursday it has acquired a four-facility nursing portfolio in the Mid-Atlantic for roughly $74.7 million. The company financed the deal through cash on hand, the real estate investment trust added. CareTrust said it signed an initial 15-year triple-net master lease with a new nursing operator, adding that...
China's WuXi explores sale of pharma units as US restrictions loom, FT reports
China's WuXi explores sale of pharma units as US restrictions loom, FT reports
Oct 3, 2024
Oct 3 (Reuters) - Chinese biotech companies WuXi AppTec and WuXi Biologics ( WXIBF ), which are being targeted by a forthcoming U.S. national security legislation, are working on sales of some of their operations, the Financial Times reported on Thursday, citing people familiar with the matter. WuXi AppTec has put its cell and gene therapy manufacturing arm WuXi Advanced...
Tesla's Model 3 Standard Range Variant No Longer Available for Order in US, Website Shows
Tesla's Model 3 Standard Range Variant No Longer Available for Order in US, Website Shows
Oct 3, 2024
05:41 AM EDT, 10/03/2024 (MT Newswires) -- Tesla's (TSLA) most affordable Model 3 variant, the Standard Range Rear-Wheel Drive, is no longer available for order in the US, the company's website showed. The Model 3 Standard Range Rear-Wheel Drive uses lithium iron phosphate battery cells from China, Reuters reported. The Model 3 Long Range Rear-Wheel Drive is now the entry-level...
China's WuXi explores sale of pharma operations as US restrictions loom, FT reports
China's WuXi explores sale of pharma operations as US restrictions loom, FT reports
Oct 3, 2024
(Reuters) -WuXi AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese biotech companies were targeted by the U.S. on national security grounds, the Financial Times reported on Thursday. WuXi AppTec has put its cell and gene therapy manufacturing unit WuXi Advanced Therapies, which operates four laboratories and manufacturing facilities in Philadelphia, up for sale,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved